By comparison, participants receiving a placebo lost only 3%
FTO status shapes the metabolic environment within which GLP-1 therapy operates which is why two people on identical protocols can report different hunger levels, different rates of weight change, and different subjective experiences of the medication's effect
Head Neck 30(1):75-84, 2008
As a melanocortin agonist, MT-II elicits a range of effects including melanogenesis for the darkening of the skin, increased lean muscle mass, and enhanced libido in male and female subjects
That said, supplementation should be done carefully
Farxigas active ingredient is dapagliflozin, which belongs to the SGLT2 (sodium-glucose cotransporter-2) inhibitor drug class and works by helping the kidneys remove excess glucose through urine